Canadian Pharmaceutical Industry in Global Value Chains: Influence of Dominant Trading Partner

DOI: 10.20542/0131-2227-2019-63-4-14-21

O. Klochko (,
National Research University Higher School of Economics, 20, Myasnitskaya Str., 101000, Moscow, Russian Federation;
I. Manuilov (,
National Research University Higher School of Economics, 20, Myasnitskaya Str., 101000, Moscow, Russian Federation

Acknowledgements. The Research is supported by the grant of the School of World Economy and International Affairs at National Research University  – Higher School of Economics No. 1-2019 “Corporate Strategies of International Companies under Global Value Chain Transformation”.

Abstract. Participation of a country in global value chains is highly dependent on types of interaction with its major trading partners. The purpose of current research is to uncover the US influence on the Canadian pharmaceutical industry insertion into global value chains. The first part of the analysis is devoted to key trends of the US and Canadian pharmaceutical industries development under the expansion of global value chains. As a result, the following hypotheses are investigated: (1) Canada’s participation in pharmaceutical value chains is mostly regional other than global; (2) Canada’s regional value added is primarily generated through cooperation with the US pharmaceutical sector; (3) dominant positions of the US corporations on the world as well as Canadian pharmaceutical markets stifle Canada’s integration into global value chains. The second part of the research describes the quantitative approach to the hypotheses testing. For instance, data from the World Input-Output Database is used to calculate the origin of value added based on the geography and product type (national and foreign value added in the exports of final and intermediate goods). The final part of the paper deals with the data interpretation and contains conclusions. Namely, it was found that pharmaceutical GVCs in North America are in fact regional for most countries and Canada is not the exception (first hypothesis proved). Further, foreign value added content of Canadian pharmaceutical exports is primarily generated in the US (second hypothesis proved). At the same time, the last hypothesis has not gained support in current research. The share of foreign value added growth during the period of 2002–2014. Thus, it can be stated that Canada has a positive experience of integration into GVCs under dominant trading partner.

Keywords: global value chains, international trade, Canada, USA, pharmaceutical sector


1. Canada Pharmaceuticals & Healthcare Report Q1 2018. London, BMI Research, 2017. 90 p.

2. Global and Russian Pharmaceuticals Market Trends Review (In Russ.) Available at: (accessed 10.07.2018).

3. UNCTAD. World Investment Report: Annex Tables. The World’s Top-100 non-financial MNEs, Ranked by Foreign Assets, 2017. Available at: (accessed 15.07.2018).

4. UNCTAD. World Investment Report: Annex Tables. Value of Net Cross-Border M&A Purchases, by Sector/Industry, 1990–2017. Available at: (accessed 15.07.2018).

5. Canada Pharmaceuticals & Healthcare Report Q3 2018. London, BMI Research, 2018. 62 p.

6. Canada’s Pharmaceutical Industry and Prospects. Kirkland (Quebec), Industry Canada, 2013. 34 p.

7. Klochko O.A. Vliyanie regional’noi integratsii na formirovanie tsepei postavok v usloviyakh globalizatsii [Impact of regional integration on creating supply chains in a globalized world]. Logistics and Supply Chain Management, 2017, no. 2(79), pp. 112-120.

8. Rugman A., Li J., Oh Ch. H. Are Supply Chains Global or Regional? International Marketing Review, 2009, vol. 26, no. 4/5, pp. 384-395.

9. Measuring and Analyzing the Impact of GVCs on Economic Development. Washington, World Bank, 2017. 189 p.

10. Rugman A.M., D’Cruz J.R. The “Double Diamond” Model of International Competitiveness: The Canadian Experience. Management International Review, 1993, vol. 33, Special issue, pp. 18-39.

11. Leontief W. Quantitative Input and Output Relations in the Economic Systems of the United States. The Review of Economics and Statistics, 1936, vol. 18, no. 3, pp. 105-125.

12. Varnavskii V. G. Mezhdunarodnaya torgovlya v kategoriyakh dobavlennoi stoimosti: voprosy metodologii [International trade in value added terms: methodological issues]. Mirovaya ekonomika i mezhdunarodnye otnosheniya, 2018, vol. 62, no. 1, pp. 5-15. DOI: 10.20542/0131-2227-2018-62-1-5-15

13. European System of Accounts (2010). Available at: (accessed 24.05.2018).

14. Jones L., Wang Z., Xin L., Degain C. The Similarities and Differences among Three Major Inter-Country Input-Output Databases and Their Implications for Trade in Value Added Estimates. Working Paper no. 2014-12B. Washington, U. S. International Trade Commission, 2014 (unpublished).

15. Eora (2018). Available at: (accessed 10.08.2018).

16. TiVA (2018). Available at: (accessed 10.08.2018).

17. International Standard Industrial Classifications of All Economic Activities, ISIC Rev. 3 (2002). Available at: (accessed 15.08.2018).

18. World Input-Output Database (WIOD). Release 2016. Input-Output Tables, 2000–2014. Available at: (accessed 10.08.2018).

19. International Standard Industrial Classifications of All Economic Activities, ISIC Rev. 4 (2008). Available at: (accessed 15.08.2018).

20. Koopman R., Wang Z., Wei S. Tracing Value-Added and Double Counting in Gross Exports. American Economic Review, 2014, vol. 104, no. 2, pp. 459-494.

21. Borin A., Mancini M. Follow the Value-Added: Tracking Bilateral Relations in Global Value Chains. MPRA Working Paper, no. 82692, 2017 (unpublished).

22. Timmer M. P., Erumban A. A., Los B., Stehrer R., de Vries G. J. Slicing up Global Value Chains. Journal of Economic Perspectives, 2014, vol. 28, no. 2, pp. 99-118.

23. Estevadeordal A., Blyde J., Suominen K. Are Global Value Chains Really Global? Policies to Accelerate Countries’ Access to International Production Networks. Geneva, International Centre for Trade and Sustainable Development, World Economic Forum, 2013. 21 p.

24. Nemova L.A. Vneshneekonomicheskie svyazi Kanady: problemy diversifikatsii [Canada’s external trade and investment relations: problems of diversification]. USA & Canada: Economics, Politics, Culture, 2016, no. 10(562), pp. 41-55.

Registered in System SCIENCE INDEX

For citation:
Klochko O., Manuylov I. Canadian Pharmaceutical Industry in Global Value Chains: Influence of Dominant Trading Partner. World Eonomy and International Relations, 2019, vol. 63, no. 4, pp. 14-21.

Comments (0)

No comments

Add comment






Dear authors! Please note that in the VAK List of peer-reviewed scientific journals, in which the main scientific results of dissertations for the degree of candidate and doctor of sciences should be published for the “MEMO Journal” the following specialties are recorded:
economic sciences:
5.2.5. World Economy.
5.2.1. Economic Theory
5.2.3. Regional and Branch Economics
political sciences:
5.5.4. International Relations
5.5.1. History and Theory of Politics
5.5.2. Political Institutions, Processes, Technologies


Current Issue
2024, vol. 68, No. 7
Topical Themes of the Issue:
  • The Supporting Structure of Global Security
  • Institutional Features of the Fourth Energy Transition
  • The Evolution of Modern German Christian Democracy
  • The Monarchies of the Persian Gulf and Central Asia
Submit an Article
The Editorial Board invites authors to write analytical articles on the following topics:
  • changes in the processes of globalization in modern conditions
  • formation of the new world order
  • shifts in civilization at the stage of transition to a digital society

The editors are also interested in publishing synthesis articles / scientific reviews revealing the main trends in the development of certain regions of the world - Latin America, Africa, South Asia, etc.